Successful Access Rate and Risk Factor of Vascular Access Surgery in Arm for Dialysis.
- Author:
Dae Woo YOO
;
Myunghee YOON
;
Hee Jae JUN
- Publication Type:Original Article
- Keywords:
Arteriovenous fistula;
Patency;
Renal insufficiency
- MeSH:
Arm*;
Arteriovenous Fistula;
Catheterization;
Central Venous Catheters;
Diabetes Mellitus;
Dialysis*;
Fistula;
Humans;
Male;
Renal Insufficiency;
Retrospective Studies;
Risk Factors*;
Transplants
- From:Vascular Specialist International
2014;30(1):33-37
- CountryRepublic of Korea
- Language:English
-
Abstract:
PURPOSE: Preservation of adequate vascular access is of vital importance for patients undergoing chronic dialysis in renal failure. The aim of this study is to evaluate the successful access rate and risk factors of arteriovenous fistula (AVF) in the arm for dialysis at a single center. MATERIALS AND METHODS: Patients undergoing vascular access operation between January 2006 and December 2011 were retrospectively identified. RESULTS: A total of 362 vascular access operations were performed. There were 338 autologous AVFs (93.4%) and 24 prosthetic grafts (6.6%). Men comprised 58.3% of all subjects. Mean age was 59.5+/-14.7 years. There were 187 diabetes mellitus patients (51.7%). There was a mean duration of 70.3+/-21.1 days between access creation to first cannulation. Overall successful access rate for dialysis was 95.9%. Of 338 autologous AVFs, 326 patients had patent AVFs for dialysis (96.4% surgical success rate), while 21 of 24 prosthetic grafts were patent (87.5% surgical success rate). A total of 141 patients (38.9%) came to surgery with preoperative central venous catheters (CVC) of which 130 (35.9%) AVFs had a patent fistula in the arm. The only risk factor related to successful access rate of AVF was preoperative CVC placement (P=0.012). CONCLUSION: Successful vascular access rate was 95.9%. The only risk factor related to patent access of AVF was preoperative CVC placement. At least 6 months prior to expected dialysis, AVF surgery is recommended, which may overcome the challenge of co-morbid conditions from having a preoperative CVC.
